Charlie's Holdings, Inc.
A distressed OTC stock facing severe profitability challenges with accelerating revenue decline and mounting operating losses.
A distressed OTC stock facing severe profitability challenges with accelerating revenue decline and mounting operating losses.
An aggressive investor might view CHUC as a deep-value turnaround candidate where the market has already priced in total failure, creating potential for asymmetric upside if management executes a successful restructuring or cost-cutting initiative. The low fixed asset base provides flexibility to pivot business models without the burden of heavy capital expenditures.
The stock presents extreme danger due to worsening fundamentals with revenue halving annually and losses expanding rapidly while cash reserves dwindle below $1M. There is no visible path to profitability given operating expenses exceeding gross profit, and the company faces an imminent risk of insolvency without further equity dilution.
Charlie's Holdings, Inc. (CHUC) is a specialized OTC-traded entity operating in a niche market segment with significant recent contraction in top-line revenue. The company reports substantial negative net income driven by high general and administrative expenses relative to its shrinking sales base. Current liquidity constraints are evident as cash reserves have declined sharply while liabilities exceed total assets.
Management has failed to arrest the downward trajectory of operations, evidenced by revenue dropping from $26.4M to $8.5M while operating expenses remained elevated at $11.9M. The cash flow from operations turned negative at -$1.6M, forcing reliance on financing cash flows of $1.5M and share issuances to maintain solvency. Despite non-cash adjustments totaling $3.5M, the company remains deeply insolvent with liabilities exceeding assets.
The broader OTC market often hosts small-cap companies facing structural headwinds, where volatility is high and financial stability is precarious. Companies in this space frequently struggle with margin compression and liquidity crunches that can lead to delisting or bankruptcy within short timeframes. Investors must scrutinize cash burn rates closely as many peers lack the financing capacity to survive prolonged downturns.
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $26.4M | $16.2M | $8.5M |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $26.4M | $16.2M | $8.5M |
| Operating Expenses | $28.2M | $18.5M | $11.9M |
| Operating Income | $-1.8M | $-2.2M | $-3.5M |
| R&D | $804.0K | $169.0K | — |
| G&A | $8.4M | $7.0M | $5.7M |
| Marketing | $2.6M | $1.1M | $693.0K |
| Stock-Based Comp | $161.0K | $286.0K | $230.0K |
| D&A | $296.0K | $154.0K | $104.0K |
| Other OpEx | $16.4M | $10.2M | $5.5M |
| Non-Operating Income | $121.0K | $109.0K | $0 |
| Interest Expense | $155.0K | $477.0K | — |
| Pre-Tax Income | $-1.7M | $-2.1M | $-3.5M |
| Income Tax | $-92.0K | $0 | $0 |
| Continuing Ops | $-1.6M | $-2.1M | $-3.5M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-1.6M | $-2.1M | $-4.2M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-1.6M | $-2.1M | $-4.2M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $5.8M | $5.1M | $3.7M |
| Accounts Receivable | $1.2M | $289.0K | $365.0K |
| Inventory | $3.7M | $3.8M | $2.7M |
| Prepaid Expenses | $780.0K | $604.0K | $477.0K |
| Other Current Assets | $257.0K | $367.0K | $211.0K |
| Long-Term Assets | $1.2M | $682.0K | $225.0K |
| PP&E (Net) | $311.0K | $157.0K | $53.0K |
| Operating Leases | $799.0K | $424.0K | $71.0K |
| Other LT Assets | $101.0K | $101.0K | $101.0K |
| Total Assets | $7.1M | $5.8M | $3.9M |
| Current Liabilities | $4.8M | $4.8M | $5.6M |
| Accounts Payable | $1.2M | $1.5M | $2.1M |
| Current Leases | $373.0K | $355.0K | $73.0K |
| Deferred Revenue | $148.0K | $58.0K | $98.0K |
| Taxes Payable | $137.0K | $128.0K | $128.0K |
| Other Current Liab | $2.9M | $2.7M | $3.1M |
| Long-Term Liabilities | $578.0K | $1.1M | $150.0K |
| LT Operating Leases | $428.0K | $73.0K | $0 |
| Other LT Liab | $150.0K | $1.0M | $150.0K |
| Total Liabilities | $5.4M | $5.9M | $5.7M |
| Shareholders' Equity | $1.7M | $-107.0K | $-1.8M |
| Paid-In Capital | $7.9M | $8.2M | $10.7M |
| Retained Earnings | $-6.4M | $-8.5M | $-12.7M |
| Total L&E | $7.1M | $5.8M | $3.9M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-1.6M | $-2.1M | $-4.2M |
| Non-Cash Adjustments | $3.4M | $2.0M | $3.5M |
| Working Capital Changes | $-3.6M | $-711.0K | $-957.0K |
| Cash from Operations | $-1.7M | $-783.0K | $-1.6M |
| Capital Expenditures | $189.0K | $0 | — |
| Cash from Investing | $-189.0K | $0 | $0 |
| Dividends Paid | $0 | — | — |
| Cash from Financing | $1.3M | $893.0K | $1.5M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $-609.0K | $110.0K | $-156.0K |
| Beginning Cash | $866.0K | $257.0K | $367.0K |
| Ending Cash | $257.0K | $367.0K | $211.0K |
Primary revenue generation relies on a single consolidated stream that has contracted from $26.4M in 2022 to just $8.5M in 2024, suggesting a lack of diversified product lines or geographic markets. The financial structure indicates heavy reliance on general and administrative overhead rather than distinct operational divisions.
The primary risk is severe liquidity distress with current liabilities of $5.6M against total assets of $3.9M and a cash deficit of $1.5M year-over-year. Revenue contraction has accelerated dramatically, falling 67% over the last two years while losses have more than doubled from 2022 to 2024. The company carries a significant retained earnings deficit of $12.7M indicating chronic unprofitability that requires external capital injections.
Potential advantages may include low-cost legacy infrastructure allowing survival despite current losses, though no specific moats are evident from the provided balance sheet data. The company maintains minimal fixed asset exposure with net fixed assets of only $53k, reducing capital expenditure burdens in a downturn.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.